{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:27:31Z","timestamp":1773098851978,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims\u2003<\/jats:title><jats:p>The Food and Drug Administration (FDA) approval of the Watchman device [percutaneous left atrial appendage occlusion (LAAO)] has resulted in the widespread use of this procedure in many centres across the USA. We sought to estimate the nationwide utilization and frequency of adverse outcomes associated with Watchman device implantation. The objective of this study was to evaluate the Watchman device implantation peri-procedural complications and comparison of the results with the previous studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results\u2003<\/jats:title><jats:p>The National Inpatient Sample (NIS) was queried for all hospitalizations with a primary diagnosis of atrial fibrillation or atrial flutter during the year 2016 with percutaneous LAAO during the same admission (ICD-10 code\u201402L73DK). The frequency of peri-procedural complications, including mortality, procedure-related stroke, major bleeding requiring blood transfusion, and pericardial effusion, was assessed. We compared the complication rates with the published randomized controlled trials and the European Watchman registry. An estimated 5175 LAAO procedures were performed in 2016. The majority of procedures was performed in males (59.1%), age \u226575\u2009years (58.7%), and White (83.1%). The overall complication rate was 1.9%. The in-hospital mortality was 0.29%. Pericardial effusion requiring pericardiocentesis was the most frequent complication (0.68%). Bleeding requiring transfusion was noted in 0.1% of device implants. The rates of post-procedure stroke and systemic embolism were 0% and 0.29%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion\u2003<\/jats:title><jats:p>Percutaneous LAAO with the Watchman device in the USA is associated with low in-hospital complications and a similar safety profile to a recently published EWOLUTION cohort. The complication rates were lower than those reported in the major randomized clinical trials (RCTs). We report the frequency of peri-procedural complications of the LAAO using the Watchman device from the NIS database. We also compare the frequency of peri-procedural complications with the previously published RCTs and EWOLUTION cohort. Our findings are in concordance with findings from EWOLUTION cohort and compare favourably with RCTs.<\/jats:p><\/jats:sec>","DOI":"10.1093\/europace\/euaa219","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T11:07:33Z","timestamp":1596971253000},"page":"247-253","source":"Crossref","is-referenced-by-count":15,"title":["Utilization and procedural adverse outcomes associated with Watchman device implantation"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8241-4324","authenticated-orcid":false,"given":"Fouad","family":"Khalil","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpkumar","family":"Arora","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Case Western Reserve University, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammar M","family":"Killu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byomesh","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Arizona, Phoenix, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher V","family":"DeSimone","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Egbe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A","family":"Noseworthy","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Kapa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siva","family":"Mulpuru","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Gersh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkhouli","family":"Mohamad","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Friedman","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Holmes","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek J","family":"Deshmukh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"2021020808561400700_euaa219-B1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMp1415738","article-title":"The Watchman saga\u2013closure at last?","volume":"372","author":"Kramer","year":"2015","journal-title":"N Engl J Med"},{"key":"2021020808561400700_euaa219-B2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.1949.02900440011003","article-title":"Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli","volume":"140","author":"Madden","year":"1949","journal-title":"JAMA"},{"key":"2021020808561400700_euaa219-B3","first-page":"2038","article-title":"Device-based approach to prevention of stroke in atrial fibrillation","volume":"6","author":"Hu","year":"2015","journal-title":"J Innov Card Rhythm Manag"},{"key":"2021020808561400700_euaa219-B4","year":"2014"},{"key":"2021020808561400700_euaa219-B5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"2021020808561400700_euaa219-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2021020808561400700_euaa219-B7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"2021020808561400700_euaa219-B8","year":"2019"},{"key":"2021020808561400700_euaa219-B9","first-page":"2010","volume-title":"HCUP Nationwide Inpatient Sample (NIS) Comparison Report. HCUP Methods Series Report","author":"Barrett"},{"key":"2021020808561400700_euaa219-B10","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.2011.551","article-title":"Coronary revascularization trends in the United States, 2001-2008","volume":"305","author":"Epstein","year":"2011","journal-title":"JAMA"},{"key":"2021020808561400700_euaa219-B11"},{"key":"2021020808561400700_euaa219-B12","year":"2018"},{"key":"2021020808561400700_euaa219-B13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion \u2013 an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"2021020808561400700_euaa219-B14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"2021020808561400700_euaa219-B15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"2021020808561400700_euaa219-B16","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2021020808561400700_euaa219-B17","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"key":"2021020808561400700_euaa219-B18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ccd.26358","article-title":"EWOLUTION: design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology","volume":"88","author":"Boersma","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"2021020808561400700_euaa219-B19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCEP.114.001413","article-title":"Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume","volume":"8","author":"Badheka","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2021020808561400700_euaa219-B20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.33963\/KP.15172","article-title":"Watchman FLX: the initial Polish experience with a new device for left atrial appendage occlusion","volume":"78","author":"Grygier","year":"2020","journal-title":"Kardiol Pol"},{"key":"2021020808561400700_euaa219-B21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ccd.26170","article-title":"2015 ACC\/HRS\/SCAI left atrial appendage occlusion device societal overview: a professional societal overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions","volume":"86","author":"Masoudi","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"2021020808561400700_euaa219-B22","year":"2015"},{"key":"2021020808561400700_euaa219-B23","year":"2015"},{"key":"2021020808561400700_euaa219-B24","doi-asserted-by":"crossref","first-page":"e003846","DOI":"10.1161\/CIRCOUTCOMES.117.003846","article-title":"With great power comes great responsibility: big data research from the National Inpatient Sample","volume":"10","author":"Khera","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2021020808561400700_euaa219-B25","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1001\/jama.2017.17653","article-title":"Adherence to methodological standards in research using the national inpatient sample","volume":"318","author":"Khera","year":"2017","journal-title":"JAMA"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/23\/2\/247\/36209350\/euaa219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/23\/2\/247\/36209350\/euaa219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T09:03:57Z","timestamp":1667725437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/23\/2\/247\/5905604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,9,14]]},"published-print":{"date-parts":[[2021,2,5]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaa219","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,9,14]]}}}